Biden
to visit Pfizer factory as Americans clamor for more COVID-19 vaccine
supply
Send a link to a friend
[February 19, 2021]
By Andrea Shalal and Michael Erman
WASHINGTON (Reuters) - President Joe Biden
heads to Kalamazoo, Michigan, on Friday to visit the Pfizer Inc
manufacturing plant that is churning out COVID-19 vaccines, as state and
local governments across the country clamor for more.
|
Biden is due to tour Pfizer's largest manufacturing site and its
only facility in the United States making the COVID-19 vaccine at a
time when less than 15% of the U.S. population is vaccinated.
The United States has rolled out ambitious vaccination programs in
recent weeks that include large sites capable of putting shots into
thousands of arms daily, as well as hospitals and pharmacies. But
officials are begging for more doses.
The Biden administration has been working to increase the number of
doses it sends out to states, cities and pharmacies every week, but
Dr. Anthony Fauci, Biden's top medical adviser, said on Tuesday that
demand far outpaced supply at the moment.
The White House said earlier this month it was using the Defense
Production Act to help Pfizer get additional equipment fast so that
it could keep ramping up production. Biden is expected to discuss
that initiative - which officials say is starting to pay dividends -
with Pfizer executives during his tour.
Pfizer has not yet delivered to the European Union about 10 million
COVID-19 vaccine doses that were due in December, EU officials told
Reuters.
Jeff Williams, mayor of Arlington, Texas, who met with Biden and
Treasury Secretary Janet Yellen in recent weeks, said his city of
400,000 was ready to vaccinate 40,000 people a day but only had
enough supply to administer 3,000 doses.
300 MILLION DOSES
Pfizer is under contract to supply the United States with 300
million doses of the two-dose vaccine it developed with Germany’s
BioNTech SE.
[to top of second column] |
The company has said it will
provide the U.S. government with 100 million
doses by the end of March and another 100
million by the end of May. It has promised the
full 300 million doses by the end of July.
As of the end of January, Pfizer had supplied
the U.S. government with about 29 million doses
of the vaccine. That is about as many doses that
had been used by Wednesday, according to U.S.
Centers for Disease Control and Prevention data.
Moderna Inc, which is also producing COVID-19 vaccine domestically,
has agreed to supply the United States with 300 million doses of its
own two-dose vaccine by the end of July.
Biden told a CNN town hall on Tuesday that everyone who wanted a
vaccine should be able to get one by July, but said the recovery
from the pandemic that has killed more than 485,000 people in the
United States would still take many months.
Globally, Pfizer and BioNTech aim to make 2 billion doses of the
COVID-19 vaccine this year. Pfizer’s chief financial officer told
Reuters earlier this month that it had recently doubled the size of
the batches of its vaccine and increased the number of batches it
was producing.
Pfizer is one of the largest employers in the Kalamazoo area, a
Democratic-leaning county in the electoral battleground state, which
Biden carried in the November election.
(Reporting by Andrea Shalal and Michael Erman; Editing by Peter
Cooney)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
|